View Past Webinars & Presentations
Dr. Rupal Shah – Interstitial Lung Disease Educational Series: Idiopathic Pulmonary Fibrosis (IPF)
Dr. Rupal J. Shah MD, MS, Associate Professor of Medicine from the University of California, San Francisco, will guide and help us explore the nature of IPF. Developed by the California Thoracic Society in collaboration with Boehringer Ingelheim Pharmaceuticals, Inc.
Dr. Matt Trump – Implementation of Nasal High Flow Before, During and After COVID-19
Learn about experiences and outcomes with Nasal High Flow both before and during COVID-19, along with observations when using the therapy after COVID-19.
Dr. Trump has been with The Iowa Clinic since 2014 and currently serves as the Medical Director for UnityPoint Pulmonary Rehabilitation. He is an instructor at Des Moines University, an Adjunct Clinical Associate Professor at The University of Iowa and section chief for the Pulmonary/Critical Care division of the University of Iowa – Des Moines Internal Medicine Residency.
Presented by Dr. Mark Trump , DO FACP FCCP Developed by the California Thoracic Society in collaboration with Fisher & Paykel Healthcare.
Brooks Thomas Kuhn, MD, MAS – Strategies to Break the Cycle of COPD Exacerbations – Education Series
Prevention of exacerbations is paramount in the management of patients with COPD, as each exacerbation leads to worse health. We will discuss a strategy for phenotyping COPD patients and exacerbations with a focus on how best to apply the expanding options of therapeutic agents and devices.
Presented by Dr. Brooks Thomas Kuhn, MD, MAS, University of California at Davis.
Developed by the California Thoracic Society in support with SmartVest (Electromed, Inc.)
Justin Oldham, MD MS – Interstitial Lung Disease – Educational Series
Discover a framework for interstitial lung disease (ILD) classification, review the ILD diagnostic work-up, and learn the importance of early ILD detection.
Justin Oldham, MD, MS, from the University of California at Davis, will take us on a deep dive into ILD. Dr. Oldham is the Assistant Professor of Medicine and the Director of the Interstitial Lung Disease Program at University of California at Davis. Developed by the California Thoracic Society in collaboration with Boehringer Ingelheim Pharmaceuticals, Inc.